Hydralazine
Brand names: Apresoline
Hydralazine is a direct-acting arterial vasodilator antihypertensive, used in resistant or severe hypertension, hypertension in pregnancy, and in heart failure combined with a nitrate.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It relaxes arteriolar smooth muscle directly, reducing systemic vascular resistance and arterial blood pressure.
Prescribing in practice
- Long-term or higher-dose use can cause a drug-induced lupus-like syndrome, which should prompt review and discontinuation.
- Reflex tachycardia and fluid retention often require co-administration of a beta-blocker and a diuretic.
- In heart failure it is combined with a nitrate, particularly where renin-angiotensin system inhibitors are unsuitable.
Monitoring
Monitor blood pressure and heart rate, and remain alert for features of a lupus-like syndrome such as arthralgia and rash.
Counselling the patient
- This medicine lowers blood pressure by relaxing the blood vessels.
- Report persistent joint pains, fever, rash or unusual tiredness.
- Do not stop the medicine suddenly without advice.
Evidence & guidelines
The combination of hydralazine with isosorbide dinitrate improved outcomes in heart failure trials, including benefit demonstrated in self-identified Black patients in the A-HeFT trial.
Reference: NICE NG133 (Hypertension in Pregnancy); Magee et al. NEJM 2015; NICE NG136; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- EDACS — Emergency Department Assessment of Chest Pain · Chest Pain
- San Francisco Syncope Rule · Syncope
- ROSE Rule for Syncope · Syncope
- Ottawa Heart Failure Risk Scale · Heart Failure
- Aortic Dissection Detection Risk Score (ADD-RS) · Aortic Disease
- REVEAL 2.0 Risk Score for Pulmonary Arterial Hypertension · Pulmonary Hypertension